PlainRecalls
FDA Drug Moderate Class II Ongoing

Metformin Hydrochloride Extended-Release Tablets, USP 750 mg, 100 count bottles, Rx Only. Manufactured by: Nostrum Laboratories, Inc. Kansas City, MO 64120. NDC 29033-056-01

Reported: November 11, 2020 Initiated: October 23, 2020 #D-0067-2021

Product Description

Metformin Hydrochloride Extended-Release Tablets, USP 750 mg, 100 count bottles, Rx Only. Manufactured by: Nostrum Laboratories, Inc. Kansas City, MO 64120. NDC 29033-056-01

Reason for Recall

CGMP Deviations: detection of N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level

Details

Recalling Firm
Nostrum Laboratories Inc
Units Affected
12,967 bottles
Distribution
Nationwide
Location
Kansas City, MO

Frequently Asked Questions

What product was recalled?
Metformin Hydrochloride Extended-Release Tablets, USP 750 mg, 100 count bottles, Rx Only. Manufactured by: Nostrum Laboratories, Inc. Kansas City, MO 64120. NDC 29033-056-01. Recalled by Nostrum Laboratories Inc. Units affected: 12,967 bottles.
Why was this product recalled?
CGMP Deviations: detection of N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level
Which agency issued this recall?
This recall was issued by the FDA Drug on November 11, 2020. Severity: Moderate. Recall number: D-0067-2021.